Harry Iland

3.5k citations
62 papers · 1.6k · 1 hit paper · h-index 19

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
    • Platelet Disorders and Treatments
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 24
    • Chronic Myeloid Leukemia Treatments 7
    • Multiple Myeloma Research and Treatments 6
    • Retinoids in leukemia and cellular processes 14

Harry Iland

62 papers receiving 1.6k citations

Harry Iland's Hit Papers

Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. 1986 · 406 citations
4060+13+26Years since publication100200300400

Peers

Harry Iland
Comparison fields: 5 of 88
  • Hematology 797
  • Genetics 534
  • Oncology 304
  • Rheumatology 145
  • Immunology 183
Replace Marcel P. Devetten with:
Marcel P. Devetten United States
Jin Takeuchi Japan
W. Heit Germany
Masamitsu Yanada Japan
Masakazu Nitta Japan
Robert Hast Sweden
J. P. Hester United States
Daniel H. Ryan United States
Angela Michelutti Italy
Aref Al‐Kali United States
Harry Iland relative to Marcel P. Devetten United States Marcel P. Devetten's profile →
Citations per field
00.5×1.6×
Marcel P. Devetten · 1×
Citations per year

Countries citing papers authored by Harry Iland

Since Specialization
Citations

This map shows the geographic impact of Harry Iland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Iland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Iland more than expected).

Fields of papers citing papers by Harry Iland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Iland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Iland. The network helps show where Harry Iland may publish in the future.

Co-authors

The 25 scholars most cited alongside Harry Iland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harry Iland Line = papers co-authored together Harry Iland links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.
Hit paper breakdown →
1986406
2 2013112
3 2011103
4 2014101
5 200778
6 201765
7 199156
8 198749
9 198746
10
Essential thrombocythemia: clinical and laboratory characteristics at presentation.
198345
11 201142
12
Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial.
199338
13 201334
14 199928
15 201828
16 200924
17
Thalidomide responsive chronic pulmonary GVHD.
199619
18 199118
19
c-fms point mutations in acute myeloid leukemia: fact or fiction?
199318
20 199415

About Harry Iland

Harry Iland is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 62 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Retinoids in leukemia and cellular processes (14 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (797 citations), Genetics (534 citations), Oncology (304 citations), Rheumatology (145 citations) and Immunology (183 citations). Harry Iland has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include John László, David S. H. Rosenthal, Seamus Murphy, John Gibson, Christina Brown, John F. Seymour, Alberto Catalano, P. Joy Ho, Derek McCulloch and Alison V. Todd. Their work appears in journals such as Blood, Pathology, American Journal of Hematology, British Journal of Haematology and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact